Antibody-drug Conjugates (ADC)

Norbornene-NHS is a versatile click chemistry reagent targeting the site-specific conjugation of biomolecules. As a dienophile, it facilitates copper-free click reactions with tetrazines, enabling efficient and selective labeling and modification. This reagent is ideal for applications in bioconjugation, protein labeling, and the development of advanced materials in chemical research.

H-Asp-Gly-OH is a cleavable ADC linker that enables the selective delivery of therapeutic agents to target cells. This compound demonstrates effective release mechanisms under specific conditions, facilitating the liberation of cytotoxic drugs in targeted therapies. It is widely utilized in the development of antibody-drug conjugates to enhance therapeutic efficacy while minimizing off-target toxicity.

Mal-PEG2-Val-Cit-PABA-PNP is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This compound features a malemide functionality for thiol conjugation, facilitating the attachment of cytotoxic agents to antibodies. Its PABA-PNP component allows for specific cleavage in the tumor microenvironment, thereby releasing the active drug and enhancing therapeutic efficacy. This linker is suitable for research applications in targeted cancer therapy development and ADC formulation studies.

SNPB is a cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This linker facilitates the targeted delivery of cytotoxic agents to tumor cells, enhancing therapeutic efficacy while minimizing off-target effects. Its unique chemical properties enable selective cleavage in the tumor microenvironment, making SNPB a valuable tool for advancing ADC research and development.

Amino-PEG4-CH2COOH is a PEG-based linker designed for use in the synthesis of proteolysis-targeting chimeras (PROTACs) and serves as a non-cleavable four-unit PEG linker for antibody-drug conjugates (ADCs). This compound facilitates the formation of stable conjugates, thereby enhancing the delivery of therapeutic agents to targeted cells. Its unique properties support research applications in targeted protein degradation and ADC development, contributing to advancements in cancer therapy and drug efficacy.

DBCO-PEG4-Val-Ala-PAB-PNP is a cleavable antibody-drug conjugate (ADC) linker designed for targeted delivery applications. The Val-Ala sequence enables selective cleavage by Cathepsin B, facilitating the release of the therapeutic payload. The incorporation of a PEG spacer enhances aqueous solubility, while the DBCO group is suitable for Click Chemistry reactions due to its reactivity. Additionally, the PNP moiety serves as an efficient leaving group, making this compound valuable in bioconjugation and therapeutic development.

Mal-amido-PEG10-C2-NHS ester is a non-cleavable ADC linker featuring a maleimide group and a reactive NHS ester. This compound is designed for the selective labeling of primary amines in proteins, amine-modified oligonucleotides, and other amine-containing molecules. Its versatile application in the development of antibody-drug conjugates (ADCs) facilitates targeted therapeutic strategies in chemical research.

Methyltetrazine-DBCO is a non-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound features a DBCO group that enables strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. Additionally, the inclusion of a tetrazine moiety allows for inverse electron demand Diels-Alder reactions (iEDDA) with trans-cyclooctene (TCO) compounds. Methyltetrazine-DBCO is an essential reagent for researchers developing targeted therapies through click chemistry methodologies.

AEEA-AEEA is a non-cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs), facilitating targeted delivery of therapeutic agents. Additionally, this alkyl chain-based linker serves as a versatile component in the construction of PROTACs (proteolysis-targeting chimeras). Its stability and efficacy make it a valuable reagent for advancing cancer research and targeted protein degradation studies.

Mal-amido-PEG5-C2-NHS ester is a non-cleavable ADC linker that features a maleimide moiety and an NHS ester. This reagent effectively conjugates to primary amines (-NH2) found in proteins, amine-modified oligonucleotides, and other amine-containing biomolecules. Its design facilitates the development of antibody-drug conjugates (ADCs) for targeted therapeutics, enabling specific and stable linking of drugs to antibodies for enhanced efficacy in research applications.

NH-bis-PEG2 is a non-cleavable linker featuring a two-unit polyethylene glycol (PEG) structure, primarily utilized in the development of antibody-drug conjugates (ADCs). This PEG-based linker is also applicable in the synthesis of PROTACs, facilitating targeted protein degradation. Its chemical properties allow for improved solubility and stability, making it a valuable tool in drug development and biochemical research.

Hydroxy-PEG6-acid is a PEG-based, non-cleavable linker designed for use in the synthesis of Antibody-Drug Conjugates (ADCs). This reagent enhances the solubility and stability of ADCs while maintaining the integrity of the antibody's targeting capabilities. It is suitable for various research applications, including the development of targeted cancer therapies and exploration of novel drug delivery systems.

Boc-NMe-Val-Val-Dil-Dap-OH is a versatile linker designed for use in antibody-drug conjugate (ADC) synthesis. This compound facilitates the covalent attachment of cytotoxic agents to antibodies, enhancing therapeutic efficacy while minimizing off-target effects. It is particularly useful in the development of targeted cancer therapies, enabling precise delivery of drugs to tumor cells.

NH-bis(C1-Boc) is an uncleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This chemical provides stability during circulation in the bloodstream, ensuring that the drug remains attached to the antibody until it reaches the target site. Its unique characteristics facilitate targeted delivery of cytotoxic agents, enhancing therapeutic efficacy in cancer research and treatment development.

Ethyl azetidine-3-carboxylate hydrochloride functions as a non-cleavable linker for antibody-drug conjugates (ADCs). It is pivotal in the formation of stable ADCs, providing effective delivery of cytotoxic drugs to targeted cancer cells. Additionally, this compound serves as an alkyl chain-based linker in the synthesis of PROTACs, enabling selective degradation of specific proteins in research applications.

FL118-C3-O-C-amide-C-NH2 serves as an effective ADC linker, playing a crucial role in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the targeted delivery of cytotoxic agents to cancer cells, thereby enhancing therapeutic efficacy while minimizing systemic toxicity. Its application in ADC development supports research in targeted cancer therapies.

N-Boc-PEG7-alcohol is a PEG-based linker primarily utilized in the synthesis of PROTACs and antibody-drug conjugates (ADCs). This cleavable linker facilitates targeted drug delivery by enhancing the solubility and stability of therapeutic compounds. Its versatile applications in chemical biology make it a valuable tool for researchers aiming to develop novel targeted therapies.

m-PEG10-amine is a non-cleavable 10 unit polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs) and PROTACs (Proteolysis Targeting Chimeras). This linker enhances the solubility and stability of conjugated biomolecules, facilitating targeted delivery and improved therapeutic efficacy. It is particularly valuable in research applications focusing on ADC development and targeted protein degradation strategies.

Propargyl-PEG4-Tos is a PEG-based linker specifically designed for the synthesis of PROTACs (proteolysis-targeting chimeras). It serves as a cleavable linker in antibody-drug conjugates (ADCs), facilitating targeted delivery of therapeutic agents. This compound features an alkyne group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc), allowing for efficient conjugation with azide-containing molecules. Its versatile applications make it a valuable tool in chemical biology and drug development research.

N-Boc-PEG6-alcohol is a PEG-based linker designed for antibody-drug conjugate (ADC) and PROTAC applications. This cleavable linker facilitates the synthesis of PROTACs, allowing for targeted degradation of specific proteins. Its unique structure provides enhanced solubility and stability, making it suitable for various biochemical studies focused on targeted therapies and protein regulation.

trans-Sulfo-SMCC is a non-cleavable crosslinker designed for antibody-drug conjugates (ADCs), known for its membrane permeability. This reagent facilitates stable linkage between antibodies and cytotoxic agents, enhancing therapeutic efficacy while ensuring targeted delivery. It is ideal for research applications focused on ADC development and the investigation of targeted drug delivery systems.

PPC-NB is a glutathione-cleavable linker designed for antibody-drug conjugates (ADCs). This compound facilitates the selective release of cytotoxic agents in targeted cancer therapy, enhancing the therapeutic index of ADCs. Its unique properties make it suitable for research applications focused on improving drug delivery systems and developing novel therapeutic strategies in cancer treatment.

Mal-PEG1-Val-Cit-PAB-PNP is a cleavable linker designed for the construction of antibody-drug conjugates (ADCs). This compound features a polyethylene glycol (PEG) spacer, allowing for flexible and stable conjugation to antibodies. It is specifically engineered to facilitate the release of cytotoxic agents in targeted therapy applications, making it valuable in cancer research and drug development.

PC SPDP-NHS carbonate ester is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the selective conjugation of therapeutic agents to antibodies, allowing for targeted drug delivery. Its functionality promotes the release of the drug in the desired cellular environment, enhancing therapeutic efficacy. Researchers utilize this linker in studies focused on improving the specificity and effectiveness of ADC-based therapies.

TCO-PEG3-Biotin is a cleavable linker designed for antibody-drug conjugate (ADC) synthesis, featuring a three-unit polyethylene glycol (PEG) backbone. This compound includes a trans-cyclooctene (TCO) moiety that facilitates click chemistry through an inverse electron demand Diels-Alder (iEDDA) reaction with tetrazine-containing molecules. TCO-PEG3-Biotin is valuable in conjugating biomolecules, enabling targeted drug delivery and enhancing therapeutic efficacy in various biological research applications.

PTAD-PEG4-alkyne is a cleavable linker designed for use in antibody-drug conjugate (ADC) synthesis. This 4-unit polyethylene glycol (PEG) linker features an alkyne functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing compounds. Its unique properties facilitate the targeted delivery of therapeutic agents, making it a valuable tool in the development of ADCs for research applications in cancer therapeutics and other fields.

MC-Val-Cit-PAB-Ispinesib is a drug-linker conjugate designed for antibody-drug conjugate (ADC) applications, featuring a cleavable linker combined with the Eg5 inhibitor, ispinesib. This compound enables the targeted delivery of cytotoxic agents to tumor cells, enhancing therapeutic efficacy while minimizing off-target effects. Its unique structure facilitates the precise synthesis of ADCs, making it a valuable tool for cancer research and development.

Modified MMAF is an ADC cytotoxin that functions by disrupting microtubule dynamics, leading to cell cycle arrest and apoptosis in cancer cells. It is primarily utilized in the synthesis of Antibody-drug Conjugates (ADCs), enhancing the specificity and efficacy of targeted cancer therapies. This compound is a valuable tool for research applications focused on cancer treatment modalities and the development of targeted drug delivery systems.

INX-SM-3 is a specialized linker designed for antibody-drug conjugates (ADCs) that incorporates glucocorticosteroid functionality. This compound enables precise delivery of therapeutic agents, enhancing the efficacy of ADCs by leveraging the anti-inflammatory properties of glucocorticosteroids. Its unique structure allows for improved stability and bioactivity, making it suitable for research applications in targeted cancer therapy and immunology studies.

P5(PEG24)-OSu is a polyethylene glycol (PEG) linker designed for antibody-drug conjugate (ADC) applications. This reagent facilitates the synthesis of PROTAC molecules, promoting targeted protein degradation. Its PEGylated structure enhances solubility and improves pharmacokinetic properties, making it a valuable tool in therapeutic research and development focused on precision medicine.

Tr-PEG4-OH is a non-cleavable four-unit polyethylene glycol (PEG) linker designed for use in antibody-drug conjugates (ADCs). Its stable structure facilitates the conjugation of cytotoxic agents to antibodies, enhancing the therapeutic efficacy while minimizing off-target effects. This linker is ideal for research applications involving ADC development and optimization for targeted cancer therapies.

Fmoc-NH-PEG6-alcohol is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This reagent plays a crucial role in enhancing the efficacy and specificity of ADCs by facilitating the controlled release of cytotoxic agents upon internalization. Its structure promotes solubility and stability, making it suitable for various research applications, including cancer therapeutics and targeted drug delivery studies.